These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 9016587
1. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Verhoef K, Tijms M, Berkhout B. Nucleic Acids Res; 1997 Feb 01; 25(3):496-502. PubMed ID: 9016587 [Abstract] [Full Text] [Related]
8. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. Murphy KM, Sweet MJ, Ross IL, Hume DA. J Virol; 1993 Dec 26; 67(12):6956-64. PubMed ID: 8230418 [Abstract] [Full Text] [Related]
11. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Wu F, Garcia J, Sigman D, Gaynor R. Genes Dev; 1991 Nov 26; 5(11):2128-40. PubMed ID: 1936997 [Abstract] [Full Text] [Related]
12. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR. Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):7791-6. PubMed ID: 10393900 [Abstract] [Full Text] [Related]
13. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells. Kim YS, Panganiban AT. J Neurosci Res; 1996 Mar 15; 43(6):652-66. PubMed ID: 8984195 [Abstract] [Full Text] [Related]
14. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides. Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ. Biochemistry; 2001 Dec 04; 40(48):14645-54. PubMed ID: 11724578 [Abstract] [Full Text] [Related]
15. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. Lisziewicz J, Rappaport J, Dhar R. New Biol; 1991 Jan 04; 3(1):82-9. PubMed ID: 2039768 [Abstract] [Full Text] [Related]
16. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element. Roebuck KA, Rabbi MF, Kagnoff MF. AIDS; 1997 Feb 04; 11(2):139-46. PubMed ID: 9030359 [Abstract] [Full Text] [Related]
17. Transactivation of heterologous promoters by HIV-1 tat. Han P, Brown R, Barsoum J. Nucleic Acids Res; 1991 Dec 04; 19(25):7225-9. PubMed ID: 1662814 [Abstract] [Full Text] [Related]
18. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S. J Hum Virol; 1999 Dec 04; 2(2):72-80. PubMed ID: 10225209 [Abstract] [Full Text] [Related]
19. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity. Ivanova G, Reigadas S, Ittig D, Arzumanov A, Andreola ML, Leumann C, Toulmé JJ, Gait MJ. Oligonucleotides; 2007 Dec 04; 17(1):54-65. PubMed ID: 17461763 [Abstract] [Full Text] [Related]
20. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Berkhout B, Gatignol A, Rabson AB, Jeang KT. Cell; 1990 Aug 24; 62(4):757-67. PubMed ID: 2201451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]